Literature DB >> 27323671

Extracranial giant cell arteritis: A narrative review.

K D F Lensen1, A E Voskuyl, E F I Comans, C J van der Laken, Y M Smulders.   

Abstract

A systematic literature search was performed to summarise current knowledge on extracranial giant cell arteritis (GCA), i.e. large-artery involvement in patients with or without clinically apparent temporal arteritis (cranial GCA). Extracranial GCA is increasingly recognised, both in patients with cranial GCA and with solitary extracranial GCA, due to increased awareness among physicians and development of modern imaging modalities. The literature on the pathogenesis and histopathology of extracranial GCA is scarce. It is considered to be similar to cranial GCA. Patients with solitary extracranial GCA often present with non-specific signs and symptoms, although vascular manifestations, mostly secondary to stenosis, may occur. Due to the non-specific clinical presentation and low sensitivity of temporal artery biopsies, extracranial GCA is usually diagnosed by imaging. 18F-FDG-PET, MRI, CT angiography and ultrasound are used for this purpose. At present, the optimal diagnostic strategy is undetermined. The choice for a particular modality can be guided by the clinical scenario that raises suspicion of extracranial GCA, in addition to local availability and expertise. Extracranial complications in GCA consist of aortic aneurysm or dissection (mainly the ascending aorta), aortic arch syndrome, arm claudication and posterior stroke (although this is technically a cranial complication, it often results from stenosis of the vertebrobasilar arteries). Mortality is generally not increased in patients with GCA. Treatment of patients with solitary extracranial and those with extracranial and cranial GCA has been debated in the recent literature. In general, the same strategy is applied as in patients with temporal arteritis, although criteria regarding who to treat are unclear. Surgical procedures may be indicated, in which case optimal medical treatment prior to surgery is important.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27323671

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  13 in total

1.  Gastric bleeding in giant cell arteritis.

Authors:  Austin Childress; Thomas J Kwarcinski; Joseph Scott H Bittle; Clayton Trimmer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-15

2.  Isolated vertebral arteritis: a challenging cause of stroke.

Authors:  Nirmeen A Kishk; Aya Alsayyad; Enas Alsayyad; Ghada Hatem
Journal:  Acta Neurol Belg       Date:  2020-02-11       Impact factor: 2.396

Review 3.  Recent Advances in Giant Cell Arteritis.

Authors:  M Guevara; C S Kollipara
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

4.  Imaging Spectrum of Granulomatous Diseases of the Abdomen and Pelvis.

Authors:  Muhammad Naeem; Christine O Menias; Austin J Cail; Maria Zulfiqar; David H Ballard; Perry J Pickhardt; David H Kim; Meghan G Lubner; Vincent M Mellnick
Journal:  Radiographics       Date:  2021-04-16       Impact factor: 5.333

5.  Giant cell arteritis manifested by chronic dry cough.

Authors:  Hiroshi Hori; Tsuyoshi Kobashigawa; Takahiko Fukuchi; Hitoshi Sugawara
Journal:  BMJ Case Rep       Date:  2020-06-21

6.  Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection.

Authors:  Bram M Voorzaat; Jan van Schaik; Stijn L P Crobach; Catharina S P van Rijswijk; Joris I Rotmans
Journal:  Case Rep Med       Date:  2017-03-06

7.  Massive B-Cell Infiltration and Organization Into Artery Tertiary Lymphoid Organs in the Aorta of Large Vessel Giant Cell Arteritis.

Authors:  Jacoba C Graver; Annemieke M H Boots; Erlin A Haacke; Arjan Diepstra; Elisabeth Brouwer; Maria Sandovici
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 8.  Giant cell arteritis: is the clinical spectrum of the disease changing?

Authors:  Miguel Á González-Gay; Miguel Ortego-Jurado; Liliana Ercole; Norberto Ortego-Centeno
Journal:  BMC Geriatr       Date:  2019-07-29       Impact factor: 3.921

Review 9.  The Immunopathology of Giant Cell Arteritis Across Disease Spectra.

Authors:  Michelle L Robinette; Deepak A Rao; Paul A Monach
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

10.  Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Yannick van Sleen; Jacoba C Graver; Wayel H Abdulahad; Kornelis S M van der Geest; Annemieke M H Boots; Maria Sandovici; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.